The FDA has approved Alnylam’s gene silencing drug ... As the kidney function worsens, oxalate can build up and damage other organs including the heart, bones and eyes. The disease is also ...
The US Food and Drug Administration (FDA) has approved the first oral treatment for anaemia caused by chronic kidney disease (CKD) in adults on dialysis for at least four months: GlaxoSmithKline ...
The kidneys are two fist-sized, bean-shaped organs located on either side of the spine. Their main purpose is to filter your blood to remove wastes and maintain fluid and electrolyte balance. The ...
FARGO — A new FDA approved drug, to help people with schizophrenia, will soon be accessible for medical officials to prescribe. It's called Cobenfy; a pill that will need to be taken twice a day.
The FDA has approved Cobenfy, the first new type of schizophrenia drug in decades. Cobenfy doesn’t appear to have the same severe side effects as older antipsychotic medicines — like weight ...
The Food and Drug Administration in late September upgraded ... 6 by the Centers for Disease Control and Prevention, and was upgraded Sept. 30 to Class I, a product that "will cause serious ...
Alembic Pharmaceutical shares jump four percent in trade on October 3, despite a sour market sentiment on receiving US FDA nod for anti-seizure drug. In an filing with the exchanges, Alembic ...
WASHINGTON--U.S. health officials on Friday approved a closely watched Alzheimer’s drug ... disease. Since then, Eisai has published the results of a larger 1,800-patient study that the FDA ...
IT WAS COLLABORATIVE FROM THE START. THE ORDINANCE PASSED 12 TO 2 AT CITY COUNCIL TUESDAY NIGHT, GOING INTO EFFECT DECEMBER FIRST. SYRINGE SERVICE PROGRAMS OR SSPS, ARE PROTECTED BY A LAW PASSED ...
the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease. The real-time PCR test, Alinity m MPXV assay, enables detection of mpox ...
In an important move to improve global access to Mpox testing, the World Health Organization (WHO) has listed the first Mpox in vitro diagnostic under its Emergency Use Listing procedure.
